UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control

Sexually transmitted infections, 2016-09, Vol.92 (6), p.447-454

2016

Volltextzugriff (PDF)

Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee

Clinical infectious diseases, 2004-07, Vol.39 (2), p.233-239

2004

Volltextzugriff (PDF)

Fluoropolymer-based Emulsions for the Intravenous Delivery of Sevoflurane

Anesthesiology (Philadelphia), 2008-10, Vol.109 (4), p.651-656

2008

Volltextzugriff (PDF)

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

Vaccine, 2008-12, Vol.26 (51), p.6671-6677

2008

Volltextzugriff (PDF)

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

Vaccine, 2000-03, Vol.18 (18), p.1902-1909

2000

Volltextzugriff (PDF)

P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P189-P189, Article P189

2009

Volltextzugriff (PDF)

Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-Adapted, Administered to Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Adults

The Journal of infectious diseases, 2000-02, Vol.181 (2), p.725-728

2000

Volltextzugriff (PDF)

Genotypic Stability of Cold-Adapted Influenza Virus Vaccine in an Efficacy Clinical Trial

Journal of Clinical Microbiology, 2000-02, Vol.38 (2), p.839-845

2000

Volltextzugriff (PDF)

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

The New England journal of medicine, 2016-04, Vol.374 (17), p.1647-1660

2016

Volltextzugriff (PDF)

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children

The Pediatric infectious disease journal, 2001-12, Vol.20 (12), p.1124-1131

2001

Volltextzugriff (PDF)

P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P201-P201, Article P201

2009

Volltextzugriff (PDF)

Light scattering by Gaussian random particles: Ray optics approximation

Journal of quantitative spectroscopy & radiative transfer, 1996-05, Vol.55 (5), p.577-601

1996

Volltextzugriff (PDF)

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis

Virus evolution, 2017-03, Vol.3 (suppl_1)

2017

Volltextzugriff (PDF)

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya

Retrovirology, 2012-09, Vol.9 (S2), p.P122-P122, Article P122

2012

Volltextzugriff (PDF)

Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda

Retrovirology, 2012-09, Vol.9 (S2), p.P116-P116, Article P116

2012

Volltextzugriff (PDF)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa

Retrovirology, 2012-09, Vol.9 (S2), p.P117-P117, Article P117

2012

Volltextzugriff (PDF)

A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study

Retrovirology, 2012-09, Vol.9 (S2), p.P135-P135, Article P135

2012

Volltextzugriff (PDF)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned

Retrovirology, 2012-09, Vol.9 (S2), p.P113-P113, Article P113

2012

Volltextzugriff (PDF)

Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda

Retrovirology, 2012-09, Vol.9 (S2), p.P126-P126, Article P126

2012

Volltextzugriff (PDF)

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.O31-O31, Article O31

2009

Volltextzugriff (PDF)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P197-P197, Article P197

2009

Volltextzugriff (PDF)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans

The Journal of infectious diseases, 2019-01, Vol.219 (4), p.556-561

2019

Volltextzugriff (PDF)

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1080-1088

1999

Volltextzugriff (PDF)

Histamine Release Associated with Intravenous Delivery of a Fluorocarbon-Based Sevoflurane Emulsion in Canines

Journal of pharmaceutical sciences, 2011-07, Vol.100 (7), p.2685-2692

2011

Volltextzugriff (PDF)

1 – 25 von 1.506

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.192)
Mit Volltextzugriff
(1.372)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(605)
Life Sciences & Biomedicine
(330)
Physical Sciences
(261)
Physics
(216)
Physics Of Elementary Particles And Fields
(216)
Humans
(191)
Biological And Medical Sciences
(139)
Female
(112)
Male
(104)
Animals
(94)
Medical Sciences
(81)
Physics, Particles & Fields
(80)
Fundamental And Applied Biological Sciences. Psychology
(74)
Technology
(70)
Middle Aged
(67)
Astronomy & Astrophysics
(65)
Immunology
(61)
Adult
(55)
Microbiology
(55)
Infectious Diseases
(51)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control

Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee

Fluoropolymer-based Emulsions for the Intravenous Delivery of Sevoflurane

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-Adapted, Administered to Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Adults

Genotypic Stability of Cold-Adapted Influenza Virus Vaccine in an Efficacy Clinical Trial

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children

P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa

Light scattering by Gaussian random particles: Ray optics approximation

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya

Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned

Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

Histamine Release Associated with Intravenous Delivery of a Fluorocarbon-Based Sevoflurane Emulsion in Canines

Suchergebnisse filtern